Skip to main content
OpenTrials

Clinical trial condition

Malignant Solid Tumor

Explore clinical trials studying Malignant Solid Tumor. Study availability and eligibility vary by location and protocol.

35 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Malignant Solid Tumor trial results

Completed

A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors

NCT03192345

Conditions
Malignant Solid Tumor
Locations
  • The University of Kansas Clinical Research Center Site Number : 8400004 Fairway, Kansas, United States
  • Massachusetts General Hospital Site Number : 8400001 Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Site Number : 8400101 Boston, Massachusetts, United States
  • Duke University Medical Center Site Number : 8400008 Durham, North Carolina, United States
View all 34 locations
View Trial Details
Completed

An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab

NCT02754141

Conditions
Malignant Solid Tumor
Locations
  • Local Institution - 0028 Chicago, Illinois, United States
  • Local Institution - 0001 Baltimore, Maryland, United States
  • Local Institution - 0022 Boston, Massachusetts, United States
  • Local Institution - 0023 Buffalo, New York, United States
View all 24 locations
View Trial Details
Completed

A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors

NCT01515306

Conditions
Malignant Solid Tumor
Locations
  • ImClone Investigational Site Ann Arbor, Michigan, United States
  • ImClone Investigational Site Detroit, Michigan, United States
  • ImClone Investigational Site New Brunswick, New Jersey, United States
  • ImClone Investigational Site Cleveland, Ohio, United States
View Trial Details

Related conditions